لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Anderson M, Collison K, Drummond MB, Hamilton M, Jain R, Martin N, Mularski RA, Thomas M, Zhu CQ, Ferguson GT

المصدر: International Journal of COPD, Vol Volume 16, Pp 933-943 (2021)

مصطلحات موضوعية: copd, inhaled triple therapy, patient outcomes, real-world studies, peak inspiratory flow rate, dpi, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://www.dovepress.com/peak-inspiratory-flow-rate-in-copd-an-analysis-of-clinical-trial-and-r-peer-reviewed-article-COPD; https://doaj.org/toc/1178-2005

URL الوصول: https://doaj.org/article/88b52ce749bb4b88a41105089794d3e8

المؤلفون: Alberto Papi, Dave Singh, J. Christian Virchow, G. Walter Canonica, Andrea Vele, George Georges

المصدر: Clinical and Translational Allergy, Vol 12, Iss 4, Pp n/a-n/a (2022)

مصطلحات موضوعية: exacerbations, inhaled corticosteroid, inhaled triple therapy, long‐acting muscarinic antagonist, long‐acting beta2‐agonist, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7022

URL الوصول: https://doaj.org/article/b9817d71f22a4019b23795acbc50bfde

المؤلفون: Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J

المصدر: International Journal of COPD, Vol Volume 12, Pp 2917-2928 (2017)

مصطلحات موضوعية: COPD, inhaled triple therapy, Beclomethasone Diproprionate, Formoterol Fumarate and Glycopyrronium Bromide., Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://www.dovepress.com/triple-therapy-in-copd-new-evidence-with-the-extrafine-fixed-combinati-peer-reviewed-article-COPD; https://doaj.org/toc/1178-2005

URL الوصول: https://doaj.org/article/29be8511015c49128f6e099296de879b

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Gary T. Ferguson, Kathryn Collison, Mike Thomas, Melanie Hamilton, Renu Jain, M. Bradley Drummond, Martin Anderson, Neil R.W. Martin, Chang-Qing Zhu, Richard A. Mularski

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Budesonide, medicine.medical_specialty, Population, patient outcomes, International Journal of Chronic Obstructive Pulmonary Disease, Fluticasone propionate, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Administration, Inhalation, Post-hoc analysis, COPD, Humans, Medicine, real-world studies, 030212 general & internal medicine, Peak flow meter, education, Original Research, Retrospective Studies, measurement_unit, inhaled triple therapy, education.field_of_study, business.industry, Dry Powder Inhalers, General Medicine, medicine.disease, Bronchodilator Agents, DPI, 030228 respiratory system, chemistry, Spirometry, measurement_unit.measuring_instrument, peak inspiratory flow rate, Vilanterol, Formoterol, business, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c501546f52d6af63b7afd5b87e4043dd
https://doi.org/10.2147/copd.s291554

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Alberto Papi, Monica Spinola, Stefano Petruzzelli, Massimo Corradi, Omar S. Usmani, Jørgen Vestbo, Dave Singh, Mario Scuri

المصدر: International Journal of COPD, Vol Volume 12, Pp 2917-2928 (2017)
International Journal of Chronic Obstructive Pulmonary Disease
Singh, D, Corradi, M, Spinola, M, Papi, A, Usmani, O, Scuri, M, Petruzzelli, S & Vestbo, J 2017, ' Triple therapy in COPD : new evidence with the extrafine fixed combination of Beclomethasone Dipropionate, Formoterol Fumarate and Glycopyrronium Bromide ', International Journal of COPD, vol. 2017, no. 12 . https://doi.org/10.2147/COPD.S146822

مصطلحات موضوعية: formoterol fumarate and glycopyrronium bromide, Time Factors, Exacerbation, Respiratory System, Review, INHALED CORTICOSTEROIDS, law.invention, Pulmonary Disease, Chronic Obstructive, DOUBLE-BLIND, 0302 clinical medicine, FLUTICASONE, Randomized controlled trial, Formoterol fumarate and glycopyrronium bromide, law, Risk Factors, Forced Expiratory Volume, Formoterol Fumarate, 030212 general & internal medicine, Lung, Fluticasone, COPD, Beclomethasone dipropionate, Inhaled triple therapy, Pulmonary and Respiratory Medicine, Health Policy, Public Health, Environmental and Occupational Health, Evidence-Based Medicine, Exercise Tolerance, biology, Beclomethasone, General Medicine, Lama, RANDOMIZED CONTROLLED-TRIAL, Metered-dose inhaler, Beclomethasone Diproprionate, Bronchodilator Agents, LUNG-FUNCTION, Drug Combinations, Treatment Outcome, Disease Progression, Public Health, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, PARALLEL-GROUP, Socio-culturale, Muscarinic Antagonists, OBSTRUCTIVE PULMONARY-DISEASE, 1102 Cardiovascular Medicine And Haematology, Formoterol Fumarate and Glycopyrronium Bromide, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Glycopyrronium bromide, Adrenergic beta-2 Receptor Agonists, Glucocorticoids, SALMETEROL/FLUTICASONE, lcsh:RC705-779, Science & Technology, business.industry, Nebulizers and Vaporizers, Environmental and Occupational Health, Recovery of Function, lcsh:Diseases of the respiratory system, biology.organism_classification, medicine.disease, Glycopyrrolate, respiratory tract diseases, EXACERBATIONS, beclomethasone dipropionat, 030228 respiratory system, business, TIOTROPIUM

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53251ada9c76aff827b0c8e59e9ba619
http://hdl.handle.net/11392/2382202